BioSpace News Archive

Business

DowDuPont Reports Second Quarter 2018 Results

GAAP EPS from Continuing Operations of $0.76; Adj. EPS Increases 41% to $1.37

August 2, 2018
·
45 min read
Business

MYOS RENS Technology Announces The Date For The Release Of Second Quarter And First Half 2018 Results, Conference Call And Webcast

MYOS RENS Technology Inc. announced that it will announce financial results for the second quarter and first half of 2018 on Wednesday, August 8 after the market closes.

August 2, 2018
·
3 min read
Business

Regeneron Reports Second Quarter 2018 Financial and Operating Results

Second quarter 2018 GAAP net income per diluted share increased by 44% to $4.82 versus second quarter 2017 and second quarter 2018 non-GAAP net income per diluted share increased 31% to $5.45 versus second quarter 2017

August 2, 2018
·
44 min read
Business

Teleflex Reports Second Quarter 2018 Results

Second Quarter Revenues of $609.9 million, up 15.4% Versus Prior Year Period; up 12.4% on Constant Currency Basis

August 2, 2018
·
37 min read
Business

AmerisourceBergen Reports Fiscal 2018 Third Quarter Results

Revenues of $43.1 Billion for the Third Quarter, an 11.5 Percent Increase Year-Over-Year

August 2, 2018
·
43 min read
Drug Development

Investigator-initiated Phase II Clinical Study of Remetinostat Started in Patients With Basal Cell Carcinoma

edivir AB announced that the first patient has been enrolled and is being dosed with remetinostat gel 1% in an investigator-initiated phase II clinical study in patients with basal cell carcinoma (BCC).

August 2, 2018
·
2 min read
Drug Development

First Patient Enrolled in Mallinckrodt’s Phase 2 Duchenne Muscular Dystrophy Trial

Trial to Assess Efficacy and Safety of Investigational Drug MNK-1411 in Patients with DMD

August 2, 2018
·
5 min read
Business

Evofem Biosciences Reports Second Quarter 2018 Financial Results and Provides Corporate Update

Phase 3 Trial of Amphora for Hormone-free Contraception Continues to Move Ahead of Schedule; Top Line Data now expected in Late 2018

August 2, 2018
·
16 min read
Business

Encision Reports First Quarter Fiscal Year 2019 Results

Encision Inc. announced financial results for its fiscal 2019 first quarter that ended June 30, 2018.

August 2, 2018
·
15 min read
FDA

ArmaGen Receives U.S. Orphan Drug Designation for AGT-184

Novel Enzyme Replacement Therapy in Development for the Treatment of Sanfilippo A Syndrome

August 2, 2018
·
3 min read